Regulatory Transparency: Forthcoming Lessons from the FDA.

European Journal of Risk Regulation Volume 1 (2010), Issue 2 Pages 159 - 162


This section discusses issues related to risk communication across a range of publicly perceived highrisk industries (such as pharmaceuticals, nuclear, oil, etc.). It reports critically and provides analysis on risk communication as an outcome of risk research within these industries. Contributions are intended to include methods working towards the advancement of risk perception research and describe any lessons learned for successfully communicating to the public about risk.


Read more


Chakraborty, S and Lofstedt, R.


May 11, 2010